Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Subcommittee OK's FDA User Fee Bill; More Debate On Third-Party Servicers To Come

Executive Summary

The House Energy and Commerce Health Subcommittee passed a bill reauthorizing FDA's device user fees May 18, along with amendments on over-the-counter (OTC) hearing aids and to streamline agency inspections of device facilities, among others. The subpanel agreed to shelve – for now – a proposed bill to facilitate off-label communications by medical product firms, and said they will wait for the full committee markup to debate a third-party servicers bill backed by imaging firms.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel